Jack T. Zilfou

3.4k total citations · 1 hit paper
19 papers, 2.7k citations indexed

About

Jack T. Zilfou is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Jack T. Zilfou has authored 19 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Oncology and 3 papers in Genetics. Recurrent topics in Jack T. Zilfou's work include Cancer-related Molecular Pathways (8 papers), Drug Transport and Resistance Mechanisms (4 papers) and RNA Interference and Gene Delivery (3 papers). Jack T. Zilfou is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Drug Transport and Resistance Mechanisms (4 papers) and RNA Interference and Gene Delivery (3 papers). Jack T. Zilfou collaborates with scholars based in United States and India. Jack T. Zilfou's co-authors include Scott W. Lowe, Maureen E. Murphy, William H. Hoffman, Jiandong Chen, S. Biade, Michael T. Hemann, Gregory J. Hannon, Ross A. Dickins, David R. Simpson and Ingrid Ibarra and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Jack T. Zilfou

19 papers receiving 2.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53

2002 658 citations William H. Hoffman, S. Biade et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jack T. Zilfou United States	15	2.1k	1.1k	485	314	208	19	2.7k
Eileen Friedman United States	36	2.1k 1.0×	1.1k 1.0×	358 0.7×	283 0.9×	308 1.5×	75	3.2k
Bill Spohn United States	13	2.4k 1.1×	1.3k 1.1×	485 1.0×	385 1.2×	202 1.0×	20	3.2k
Ricardo Sánchez‐Prieto Spain	26	1.3k 0.6×	696 0.6×	374 0.8×	252 0.8×	144 0.7×	74	2.1k
Emma Shtivelman United States	33	2.4k 1.2×	931 0.8×	602 1.2×	279 0.9×	386 1.9×	42	4.2k
Rieko Ohki Japan	21	2.3k 1.1×	1.2k 1.1×	445 0.9×	194 0.6×	216 1.0×	50	3.0k
Simona Ronzoni Italy	17	2.2k 1.1×	1.3k 1.2×	659 1.4×	168 0.5×	206 1.0×	29	3.2k
Peiwen Fei United States	23	1.8k 0.9×	825 0.7×	576 1.2×	202 0.6×	217 1.0×	51	2.3k
J I Johnson United States	7	1.3k 0.6×	853 0.7×	316 0.7×	148 0.5×	187 0.9×	7	2.0k
Zhi-Min Yuan United States	35	3.0k 1.4×	1.6k 1.4×	554 1.1×	163 0.5×	345 1.7×	61	3.8k
Isabella Manni Italy	25	1.9k 0.9×	785 0.7×	494 1.0×	171 0.5×	218 1.0×	57	2.5k

Countries citing papers authored by Jack T. Zilfou

Since Specialization

Citations

This map shows the geographic impact of Jack T. Zilfou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack T. Zilfou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack T. Zilfou more than expected).

Fields of papers citing papers by Jack T. Zilfou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack T. Zilfou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack T. Zilfou. The network helps show where Jack T. Zilfou may publish in the future.

Co-authorship network of co-authors of Jack T. Zilfou

This figure shows the co-authorship network connecting the top 25 collaborators of Jack T. Zilfou. A scholar is included among the top collaborators of Jack T. Zilfou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack T. Zilfou. Jack T. Zilfou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Zilfou, Jack T. & Scott W. Lowe. (2009). Tumor Suppressive Functions of p53. Cold Spring Harbor Perspectives in Biology. 1(5). a001883–a001883. 432 indexed citations

Humbey, Olivier, Julia Pimkina, Jack T. Zilfou, et al.. (2008). The ARF Tumor Suppressor Can Promote the Progression of Some Tumors. Cancer Research. 68(23). 9608–9613. 43 indexed citations

Pimkina, Julia, Olivier Humbey, Jack T. Zilfou, Michal Jarník, & Maureen E. Murphy. (2008). ARF Induces Autophagy by Virtue of Interaction with Bcl-xl. Journal of Biological Chemistry. 284(5). 2803–2810. 75 indexed citations

Hartman, Tiffiney R., Dongyan Liu, Jack T. Zilfou, et al.. (2008). The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway. Human Molecular Genetics. 18(1). 151–163. 107 indexed citations

Bosco, Emily E., Ying Wang, Huan Xu, et al.. (2006). The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer. Journal of Clinical Investigation. 117(1). 218–228. 150 indexed citations

Reed, Michael F., W Zagórski, John A. Howington, Jack T. Zilfou, & Erik S. Knudsen. (2006). Inhibition of Retinoblastoma Tumor Suppressor Activity by RNA Interference in Lung Cancer Lines. The Annals of Thoracic Surgery. 82(1). 249–253. 3 indexed citations

Dickins, Ross A., Michael T. Hemann, Jack T. Zilfou, et al.. (2005). Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nature Genetics. 37(11). 1289–1295. 419 indexed citations

Hemann, Michael T., Jack T. Zilfou, Zhen Zhao, et al.. (2004). Suppression of tumorigenesis by the p53 target PUMA. Proceedings of the National Academy of Sciences. 101(25). 9333–9338. 146 indexed citations

Hemann, Michael T., Jordan S. Fridman, Jack T. Zilfou, et al.. (2003). An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nature Genetics. 33(3). 396–400. 280 indexed citations

10.

Hoffman, William H., S. Biade, Jack T. Zilfou, Jiandong Chen, & Maureen E. Murphy. (2002). Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53. Journal of Biological Chemistry. 277(5). 3247–3257. 658 indexed citations breakdown →

11.

Smith, Christopher, Christina Myers, Jack T. Zilfou, S.N. Smith, & David S. Lawrence. (2001). Indoloquinoxaline Compounds That Selectively Antagonize P-Glycoprotein. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 12(5). 219–229. 14 indexed citations

12.

Shen, Hongxie, et al.. (2001). Binding of the aminothiol WR-1065 to transcription factors influences cellular response to anticancer drugs.. PubMed. 297(3). 1067–73. 36 indexed citations

13.

Shen, Hongxie, et al.. (2001). Binding of the Aminothiol WR-1065 to Transcription Factors Influences Cellular Response to Anticancer Drugs. Journal of Pharmacology and Experimental Therapeutics. 297(3). 1067–1073. 16 indexed citations

14.

Zilfou, Jack T., et al.. (2001). The Corepressor mSin3a Interacts with the Proline-Rich Domain of p53 and Protects p53 from Proteasome-Mediated Degradation. Molecular and Cellular Biology. 21(12). 3974–3985. 103 indexed citations

15.

Lawrence, David S., Jack T. Zilfou, & Charles D. Smith. (1999). Structure−Activity Studies of Cerulenin Analogues as Protein Palmitoylation Inhibitors. Journal of Medicinal Chemistry. 42(24). 4932–4941. 85 indexed citations

16.

Smith, Charles D., Jack T. Zilfou, Xinqun Zhang, Gary R. Hudes, & Kenneth D. Tew. (1995). Modulation of P-glycoprotein activity by estramustine is limited by binding to plasma proteins. Cancer. 75(10). 2597–2604. 12 indexed citations

17.

Smith, Charles D. & Jack T. Zilfou. (1995). Circumvention of P-glycoprotein-mediated Multiple Drug Resistance by Phosphorylation Modulators Is Independent of Protein Kinases. Journal of Biological Chemistry. 270(47). 28145–28152. 44 indexed citations

18.

Zilfou, Jack T. & Charles D. Smith. (1995). Differential interactions of cytochalasins with P-glycoprotein.. PubMed. 7(9). 435–43. 11 indexed citations

19.

Smith, Charles D., Jack T. Zilfou, Klemens Stratmann, Gregory M. L. Patterson, & Richard E. Moore. (1995). Welwitindolinone analogues that reverse P-glycoprotein-mediated multiple drug resistance.. Molecular Pharmacology. 47(2). 241–247. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact